Searchable abstracts of presentations at key conferences in endocrinology

ea0085oc5.5 | Oral Communications 5 | BSPED2022

The lack of genotype: phenotype correlations in rare causes of primary adrenal insufficiency highlights the need for genetic testing

Maitra Saptarshi , Smith Christopher , Hall Charlotte , Read Jordan , Maharaj Avinaash V , Mariela Marroquin Ramirez Lucia , Qamar Younus , Prasad Rathi , Chan Li F , Metherell Louise A

Background: Primary adrenal insufficiency (PAI) can be associated with significant morbidity in children of all ages, the most common cause being Congenital Adrenal Hyperplasia (CAH). Several other rare inherited causes of PAI have been identified over the years which lack diagnostic phenotypic or biochemical signs, leaving genetic testing as the only approach to make a definitive diagnosis. Our cohort involves >440 patients who presented with features of PAI – hypogl...

ea0090oc5.4 | Oral Communications 5: Adrenal and Cardiovascular Endocrinology 1 | ECE2023

Adrenal Insufficiency Associated with Biallelic Mutations in Porphyria Genes

Smith Chris , Jackson Adam , Al-Salihi Ahmed , Janecke Andreas , Steichen Elisabeth , Darby Denise , Griffin Liezel , Banka Siddharth , Elsayed Solaf , Chan Li , Metherell Louise

Adrenal insufficiency (AI) is life-threatening and can present alone or in combination with other co-morbidities. Here we describe families with a novel association of AI with porphyria caused by biallelic mutations in protoporphyrinogen oxidase (PPOX) or coproporphyrinogen oxidase (CPOX). The porphyrias are a group of disorders caused by defects in one of eight enzymes within the haem biosynthetic pathway, divided into acute porphyrias, resulting in mainly n...

ea0090p1 | Adrenal and Cardiovascular Endocrinology | ECE2023

Crinecerfont (NBI-74788), a Novel CRF1 Receptor Antagonist, Lowers Adrenal Androgens and Precursors in Adolescents with Classic Congenital Adrenal Hyperplasia

Newfield Ron , Sarafoglou Kyriakie , Fechner Patricia Y. , Nokoff Natalie J. , Auchus Richard , Vogiatzi Maria , Giri Nagdeep , Roberts Eiry , Sturgeon Julia , Chan Jean L. , Farber Robert

Introduction: Classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21OHD) is a rare autosomal recessive disorder characterized by deficiency of cortisol and oftentimes aldosterone, with elevated adrenocorticotropic hormone (ACTH) and steroid precursors that are shunted toward excess androgen production. A phase 2 study of adults with classic 21OHD demonstrated that crinecerfont–an oral, non-steroidal, selective corticotropin-releasing factor type...

ea0090p560 | Adrenal and Cardiovascular Endocrinology | ECE2023

Genetic Aetiology of Primary Adrenal Insufficiency in Sudan

Smith Chris , Abdullah Mohamed , Hassan Samar , Qamar Younus , Hall Charlotte , Maitra Saptarshi , Maharaj Avinaash , Mariela Marroquin Ramirez Lucia , Read Jordan , Chan Li , Metherell Louise , Musa Salwa

Primary adrenal insufficiency (PAI) in children is usually congenital with more than 25 causal genes leading to overlapping phenotypes. A genetic diagnosis is helpful to guide management and genetic counselling but can be challenging in resource limited settings where facilities for antibodies and genetic testing may be unavailable. Studies from Africa are rare but, in Sudan, the most common genetic aetiologies for PAI are congenital adrenal hyperplasia (CAH; mostly CYP21A...

ea0067o18 | Oral Presentations | EYES2019

Transcriptome profiling explains clinical characteristics of PRKACA mutant cortisol-producing adenomas

Kim Jung Hee , Jang Insoon , Kim Su-Jin , Song Ra-Young , Kim Kwang Soo , Lee Hyun-Seob , Seong Moon Woo , Shin Chan Soo , Lee Kyu Eun

Objectives: The activating mutation (L206R) in PRKACA has been reported in more than 30–50% of cases with cortisol-producing adenomas (CPAs). We aimed to compare the clinical characteristics and gene expression profiling between PRKACA L206R mutant and wild type CPAs.Methods: We included 57 subjects with CPAs who underwent adrenalectomy at Seoul National University Hospital. Sanger sequencing for PRKACA w...

ea0037gp.27.01 | Thyroid – hyperthyroidism and treatment | ECE2015

The effect of TSH suppression therapy on the cortical bone geometry in the patients with differentiated thyroid cancer

Moon Jae Hoon , Choi Hoon Sung , Jung Chan Hyun , Kim Kyung Young , Park Young Joo , Park Do Joon , Kim Kyong Yeun

Background: TSH suppression therapy has been associated with hip and vertebral fracture. However, the relationship between TSH suppression and bone mineral density (BMD) remains controversial. The aim of this study was to evaluate the effect of TSH suppression therapy on cortical bone geometry in differentiated thyroid cancer (DTC) patients.Methods: This study included 122 subjects (19 men, 27 premenopausal women, and 75 postmenopausal women) who have be...

ea0033oc1.7 | Oral Communications 1 | BSPED2013

A mutation in thioredoxin reductase 2 is associated with familial glucocorticoid deficiency

Prasad Rathi , Chan Li , Hughes Claire , Kaski Juan , Kowalczyk Julia , Savage Martin , Peters Catherine , Nathwani Nisha , Clark Adrian , Storr Helen , Metherell Louise

Background: Novel pathogenic mechanisms involving replicative and oxidative stress have recently been described in familial glucocorticoid deficiency (FGD); including mutations in NNT. NNT supplies high concentrations of NADPH needed by the glutathione and thioredoxin anti-oxidant systems to detoxify mitochondrial H2O2.Six patients, from a consanguineous Kashmiri family, were diagnosed with glucocorticoid deficiency between...

ea0019oc31 | Bone and Calcium | SFEBES2009

A mouse with a Trp589Arg mutation in N-acetylgalactosaminyltransferase 3 (Galnt3) provides a model for familial tumoural calcinosis

Esapa C , Head R , Chan C , Crane E , Cheeseman M , Hough T , McNally E , Carr A , Thomas G , Brown M , Croucher P , Brown S , Cox R , Thakker R

Investigations of bone disorders which are often inherited have yielded important insights in the molecular mechanisms of bone development, osteoporosis and osteoarthritis. However, these studies have been hampered by the lack of available patients and affected families. To overcome this limitation, we have investigated mice treated with the chemical mutagen N-ethyl-N-nitrosourea (ENU) for hereditary bone disorders. Mice were kept in accordance with national welf...

ea0017p23 | (1) | BSPED2008

Prepubertal Cushing's disease: diagnosis and therapeutic outcome

Kumaran A , Chan LF , Martin L , Afshar F , Matson M , Plowman PN , Monsoon JP , Besser GM , Grossman AB , Savage MO , Storr HL

Cushing’s disease (CD) is very rare in prepubertal children, and remains a challenge to diagnose and manage. We review the diagnostic features and therapeutic outcome of prepubertal (defined as testicular volume <4 ml (M) and breast stage <2 (F)) CD patients treated in a single centre. Fifteen prepubertal patients (median age 9.4 years; range 5.8–13.7) fulfilled standard diagnostic criteria for CD and there was male preponderance (12 M (80%), median age 9.1 y...

ea0009p66 | Growth and development | BES2005

The circadian rhythm of osteoprotegerin and its association with parathyroid hormone secretion

Joseph F , Chan B , Corlett P , Durham B , Ahmad A , White H , Wherley N , Vinjamuri S , Gallagher J , Fraser W , Vora J

BACKGROUD: Parathyroid hormone (PTH) is normally secreted in a circadian rhythm and modulates bone turnover through the differential stimulation of receptor activator for nuclear factor kappa-B ligand (RANKL) and suppression of osteoprotegerin (OPG), both of which are fundamental factors in regulating bone turnover. We have studied the relationship between PTH and OPG over a 24-hour period.METHODS: Hourly peripheral venous blood samples were obtained fro...